Roger D. Tung, Chief Executive Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 23,740 shares at $3.09 ($29K) on 2022-01-06, disclosed to the SEC on 2022-01-07.
Scheduled sale ($29k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 7,000 | $0 | 0.0% |
| 2 | $0.00 | 7,500 | $0 | 0.0% |
| 3 | $3.09 | 9,240 | $29K | 100.0% |
| Total | $1.20 avg | 23,740 | $29K | 100% |
| Filing → |
| CNCE | SELL | 2021-12-15 | $24K | — | Filing → |
| CNCE | SELL | 2021-02-17 | $97K | — | Filing → |
| CNCE | BUY | 2016-05-12 | $414K | — | Filing → |